Does Medicaid cover GLP-1 medications?
medicaid
Medicaid is the federal-state health insurance program for low-income individuals; coverage varies significantly by state.
State Medicaid coverage of GLP-1s for weight loss varies widely. Most states cover for diabetes; about 13 states cover Wegovy/Zepbound for weight loss under specific conditions as of 2026.
Medicaid coverage by drug
- Varies by planWegovysemaglutide
State Medicaid coverage of Wegovy varies dramatically. Approximately 13 states cover Wegovy under specific clinical criteria (often higher BMI thresholds than commercial). Check your state's Medicaid formulary.
- Varies by planZepboundtirzepatide
State coverage of Zepbound mirrors Wegovy patterns. Fewer states currently cover Zepbound than Wegovy due to formulary timing.
- CoveredOzempicsemaglutide
Most state Medicaid programs cover Ozempic for type 2 diabetes with prior authorization.
- CoveredMounjarotirzepatide
Most state Medicaid programs cover Mounjaro for diabetes with prior auth.
- Varies by planSaxendaliraglutide
State coverage of Saxenda varies; coverage is often more permissive than Wegovy because Saxenda is older but is being deprioritized as newer agents enter.
Reminder: coverage varies by plan
Medicaid offers many plan designs. The same medication can be covered under one Medicaid plan and excluded from another. Always confirm with your specific plan's formulary or call the number on your insurance card before assuming coverage.
Frequently asked
Does Medicaid cover GLP-1 medications for weight loss?+
State Medicaid coverage of GLP-1s for weight loss varies widely. Most states cover for diabetes; about 13 states cover Wegovy/Zepbound for weight loss under specific conditions as of 2026. GLP-1 coverage at Medicaid varies plan by plan. For Wegovy and Zepbound (weight-loss indications), expect prior authorization at minimum, with formal documentation of BMI and previous lifestyle interventions. For Ozempic and Mounjaro (type 2 diabetes), coverage is generally easier when prescribed for diabetes.
Does Medicaid require a prior authorization for Wegovy or Zepbound?+
Yes, prior authorization (PA) is the norm for weight-loss GLP-1s across Medicaid plans. A PA typically requires documented BMI ≥30 (or ≥27 with a comorbidity), prior attempts at structured weight loss, and sometimes step-therapy through cheaper alternatives. Your prescriber's office files the PA — the typical turnaround is 3-15 business days.
How do I check if my specific Medicaid plan covers a drug?+
Three steps: (1) Log into your Medicaid member portal and search the drug formulary by name. (2) Call the member services number on your insurance card. (3) Ask your prescriber to submit a benefits inquiry. Plan designs differ widely within Medicaid — what's covered for one member may not be covered for another.
What if Medicaid denies my GLP-1 prior authorization?+
Three options: (1) Appeal — most plans grant an appeal that adds physician peer-to-peer review; your prescriber can request this. (2) Switch indication if clinically appropriate (e.g., if you have prediabetes and BMI ≥30, your physician may have different coverage paths). (3) Use manufacturer direct-pay (NovoCare, LillyDirect) which doesn't depend on insurance approval. Federal program coverage policies follow CMS rules and have less plan-by-plan variability — appeals are still available.
Are compounded GLP-1s covered by Medicaid?+
Generally no. Most insurance plans, including Medicaid, do not cover compounded semaglutide or tirzepatide regardless of pharmacy. As of 2026, the FDA is winding down large-scale compounding, so coverage questions are increasingly moot — most patients are transitioning to branded GLP-1s or manufacturer direct-pay programs.